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Objectives: To evaluate the diagnostic accuracy of smear and culture tests of
clinical samples of pulmonary tuberculosis after the introduction of the directly
observed treatment short-course (DOTS) program.
Methods: Using sputum samples from 572 individuals as a self-selected pop-
ulation, both ZiehleNeelsen staining and culturing on LowensteineJensen
medium were carried out as diagnostic procedures. Using Bayes’ rule, the
obtained data set was analyzed.
Results: Of the 572 samples, 33 (0.05769) were true positive (results of both tests
positive) cases; 22 samples (0.03846) were false positive (smear test positive and
culture test negative) cases; 62 samples (0.10839) were false negative (smear
test negative and culture test positive) cases; and 455 samples (0.79545) were
true negative (results of both tests negative) cases. Values of test statistics,
sensitivity, and specificity were used to compute several inherent other Bayesian
test statistics. The a priori probability or prevalence value of tuberculosis in the
targeted population was 0.166. The a posteriori probability value computed
arithmetically was 0.6614 and that obtained by the graphical method was 0.62.
Conclusions: The smear test was found to be dependable for 95.4% with stable
TB infections, and it was not dependable for 34.7% without stable TB infections.
The culture test could be regarded as the gold standard for 96.15% as seen with
the data set, which was obtained after the implementation of the DOTS program.ted under the terms of the Creative Commons Attribution Non-Commercial License (http://
0) which permits unrestricted non-commercial use, distribution, and reproduction in any
roperly cited.
ase Control and Prevention. Published by Elsevier Korea LLC. All rights reserved.
46 S. Rath, et al1. Introduction was launched in the same year; however, the programTuberculosis, caused by tubercle bacilli (TB), spreads
by droplet infection, via an aerosol sneezed by a patient. In
immune-compromised/aged individuals, those with poor
health, those infected with HIV, and those living in poor
hygienic conditions, TB attacks through the upper respi-
ratory tract (URT), and after a dormant period, the disease
is expressed [1]. Sometimes, a TB strain causes URT
infections , and when consulting a clinician the infected
individual is routinely advised to undergo a rapid diag-
nostic testdthe acid-fast bacillus (AFB) staining or
ZiehleNeelsen staining (ZN staining or smear test, cited
herein). Typically, this method requires a critical pop-
ulation of bacilli (5e10  103 bacilli/mL) in the clinical
(sputum) sample from an infected person for the positivity
of the test result [2]. However, a smear test can turn up
a negative result, if there is only a small number of bacilli in
the sputum sample. Concomitant to diagnosis by a smear
test, sputum samples are routinely sent for culturing in
LowensteineJensen (LeJ) medium. Unfortunately, in TB
it takes 3e4 weeks for colonies to develop, during which
time the disease becomes stable in the infected individual.
Indeed, this test (culture test, cited herein) is regarded as
the gold standard, because viable bacilli in the sputum
sample grow into colonies in the LeJ medium [3].
The unfortunate situation is that false negative (FN)
cases (results where the smear test is negative and the
culture test is positive) lead to cryptic invasions of bacilli
that progress toward the establishment of the disease, as
a negative smear test result prompts the decision for
nontreatment (to control the infection), and when culture
test results become available later (after 1 month or so),
the person has already contracted the disease [4]. There-
fore, to prevent this, clinicians usually recommend for
patients to undergo empirical TB chemotherapy. When
a patient is on chemotherapy, he/shemay sometimes have
a sufficient amount of dead bacilli to yield “smear test
positivity alongwith culture test negativity”, giving rise to
false positive (FP) cases. The other two obvious possi-
bilities are the positivity of both tests, i.e., true positive
(TP) cases (smear test positivity and culture test posi-
tivity) and the negative results of both tests, i.e., true
negative (TN) cases (smear test negativity and culture test
negativity), which can be suitably taken care of by the
clinician. The confusing ambivalence of FN and FP cases
creates clinical ambiguity, i.e., persons with FN cases are
not given chemotherapy unlessmultiple comorbidities are
evident, leading to the establishment of the disease. By
contrast, FP patients, particularly those with a small
number of bacilli, are unnecessarily subjected to
a rigorous regimen of chemotherapy. In addition, FP cases
may arise from infection from mycobacteria other than
tuberculosis (MOTT).
This hospital was converted into a teaching hospital
in 2007, and the Revised National TB Control Programonly became effective from December 2009 onward.
The samples were collected from suspected patients,
who at times had been treated with the directly observed
treatment short-course (DOTS) protocol, which was
instituted by the World Health Organization [5]. The
DOTS strategy involves the treatment of TB patients for
the first 2 months with the first-line drugs of chemo-
therapy [6]. There were also provisions for intermediate
dosing of drugs three times weekly, and at times twice
weekly, although this was not recommended by the
World Health Organization, because margins of error
stemming from accidentally omitting one dose per week
may result in once-weekly dosing, which would virtu-
ally render the treatment ineffective. It had been recor-
ded that the implementation of DOTS has a success rate
exceeding 95% and that it prevented the emergence of
further MDR-TB strains [7]. It should be noted that the
DOTS-plus program meant for MDR-TB was not
introduced in this study, because it involves drug
sensitivity testing as a routine procedure; thus, patients
were treated under resource-limited settings. Data pre-
sented here were from a period of 19 months, as
recorded from patients in areas where the DOTS
program was implemented. This work is an extension of
our previous work of 5 years [8], which was conducted
in a community where the DOTS program was not used.
This report describes the prevalence of tuberculosis after
the program has been implemented. Thus, this work
substantiates, with a reasonable interval after the
previous study, the use of the DOTS program in and
around this TB center with a view toward examining its
aftermath in a typical state of India.
1.1. Why Bayesian analysis?
In a population of suspected patients who donated
sputum samples, four types of situations were noted.
Obviously, a clinician would be eager to know numer-
ically about the errors of each test, which gave rise to
FN and FP cases. Therefore, degrees of fallibility of
both tests need be assessed. To resolve the ambiv-
alencedhow specific and sensitive are these tests?d
Bayesian analysis can be used [9]. As with any disease,
for TB, an affirmative diagnostic procedure becomes
essential in order to determine the presence/absence of
a disease in a patient. Two types of false cases, FN and
FP cases, arise as errors unbeknown to the clin-
iciandthe first type of error is the treatment of healthy
people suspected of being infected, and the second is
allowing infected patients to go untreated in a commu-
nity of healthy individuals [10]. The first type of error
results in morbidity linked to first-line and second-line
drugs [6], whereas the impact of the second type is
even more grave, in that the infection subtly spreads to
the rest of the patient’s body as well as to the commu-
nity. This situation could lead to serious consternation in
issues of public health [6]. Thus, a suitable test to
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culture test results is essential.
Data could be presented in a 2  2 generic format,
for which only the Bayesian concept can be used, as the
culture test is considered the gold standard [11]. The
data set could then be used to assess the prevalence of
tuberculosis in the targeted population as a post hoc trial
from 572 samples; in addition, the digital assessment of
the credibility of the smear test could be performed. As
the culture test also has its degree of fallibility, i.e.,
unviable bacilli as discussed above may give rise to
positivity in the smear test and negativity in the culture
test, its quantification also remains an obvious quest.
Diagnostic tests are used to reveal the occurrence of
a disease in a population consisting of randomly
distributed diseased and disease-free individuals, and the
accuracy of a diagnostic test can be measured by
comparing the test results to the true condition of
patients individually. Herein, the ambivalence of smear
and culture tests could be resolved with the account of
data as evidenced by an appropriate statistical analysis
involving probabilitydas the extent of how dependable
each test is. Obviously, an ideally based truth is required
with which the second test can be compareddthe smear
test is to be assessed. Therefore, with care, the Bayesian
analysis based on evidence could measure the degree of
belief/assumption: first, at what percentage can the
culture test be taken as the gold standard, and second, to
what extent, numerically, can the smear test be consid-
ered dependable for the start of TB chemotherapy?
To evaluate the inherent probability of each test, the
prior probability (a priori probability or prevalence or
the prevalence of disease in the targeted population) is
determined before using the data. Prevalence is
computed as (TP þ FN)/N, where N is the total number
of samples. Additionally, several test statistics are
associated in the analysis:
1. The sensitivity (TP rate) is the proportion of people
with the disease who will have positive smear test
results, computed by [TP/(TP þ FN)]. This value is
the ability of the smear test to detect the infection
status, when it is truly present, i.e., it is the proba-
bility of a positive test result, given that the samples
were taken from sick individuals.
2. The specificity (TN rate) is the proportion of people
without the disease who will have negative smear
test results, obtained by [TN/(FP þ TN)]. This value
is the ability of the smear test to yield a negative
result with samples from disease-free individuals,
i.e., it is the probability of a negative test result.
3. The FP rate is the probability of errors in the culture
test, computed as [FP/(FP þ TN)].
4. The FN rate is the probability of errors in the smear
test, computed as FN/(TP þ FN).
5. The positive predictivity is the posttest probability
of the disease that yielded a positive test result, orthe probability of the portion of people with positive
test results who actually had the disease, computed
as [TP/(TP þ FP)].
6. The negative predictivity is the posttest probability
of the disease that gave a negative test result, or the
probability of the proportion of people with nega-
tive test results who actually did not have the
disease, computed as [TN/(FN þ TN)].
7. The diagnostic accuracy (inherent validity or
predictive validity) is the ability of the smear test to
be correctly positive or negative, among the binary
results of the culture test, computed as [(TP þ TN)/
N]. Additionally, this value estimates the accuracy
of smear and culture tests together.
8. The positive likelihood ratio (LR) is the ratio
between the TP rate and the FP rate, computed as
[sensitivity/(1  specificity)], when the smear test
result was positive.
9. The negative LR is the ratio between the FN rate and
the TN rate, computed as [(1  sensitivity)/speci-
ficity], when the smear test result was negative. In
fact, the larger is the positive LR value, the greater
the likelihood of infection, and similarly, the lesser
is the negative LR value, the lesser the likelihood of
infection in a population.
10. The a posteriori probability is the value from
posttest arithmetic computation of the data set for
the diagnostic efficiency, and it clarifies the
dependability of each test independently, with
a numerical probability value in arriving at the truth,
i.e., the sought-after conclusions from both tests.
11. The area under the receiver operating characteristic
(ROC) curve, drawn with values of sensitivity and
1  specificity, gives a graphical analysis for diag-
nostic efficiency. The graphical method additionally
examines the predictive capability as another value
of a posteriori probability, independent of the
arithmetic computation.2. Materials and Methods
SumHospital, Bhubaneswar, is a philanthropic clinical
teaching hospital with a recognized TB center. During the
18months of study, persons of all age groups suspected of
having pulmonary tuberculosis contributed fresh sputum
samples, which were subjected to AFB/smear test and
culturing in the LeJ medium on the same day. An aliquot
of 5mLof a samplewas added to a volume of 10mLof 4%
NaOH in a centrifuge tube that was placed for 15 minutes
in a water bath at 37 C, for the digestion of mucus. The
tube was centrifuged at 3000 g for 20 minutes; the
supernatant was discarded, and the residue was washed
three times with sterile distilled water [12]. A smear was
prepared using two droplets of the suspension on a glass
slide, and this was air dried; drops of 1% carbol-fuchsin
were poured onto the smear. Next, the slide was heated
48gently and was allowed to stand for 10 minutes for the
coloration of the smear. The slide was gently washed with
water and was decolorized with drops of 25%H2SO4. The
smear was further counterstained with 0.1% methylene
blue solution for 1 minute, and was gently washed before
air-drying. At least 200e300 fields under an oil immer-
sion objective were screened for red/pink AFB, and
results were recorded as 0e1, 1e9, or 10e99 or more
AFB per field (Figure 1). Results were reported, viewing
under 100 fields, as follows: (1) negative with no red/pink
bacteria, (2) scanty for 1e9 bacilli, (3) þ for 10e99
bacilli, (4) þþ for more than 100 bacilli, or (5) þþþ for
bacilli more than 100 per field [13]. Furthermore, dupli-
cate tubes of the LeJ medium were inoculated from the
prepared suspension and were incubated at 37 C for the
growth of colonies that were checked later, in 6e8 weeks
with weekly intervals.
3. Results
Diagnostic analyses of 572 sputum samples (NZ1.0)
obtained in a period of 19 months (March 2010 to
September 2012) were performed with a smear test and
culture test, in a parallel manner. It was found that from
a total of 572 samples (NZ 1.0), 33 samples (0.05769)
were TP cases; 22 samples (0.03846) were FP cases; 62
samples (0.10839) were FN cases; and 455 samples
(0.79545) were TN cases. It was evident that there was
mismatch of results in the two tests, so FN and FP cases
arose (Table 1). Applying the Bayesian concept with the
recorded data (Table 1), several other test statistics
described earlier could be computed for additional prob-
ability values, with 95% confidence interval (CI) values
(Table 2).
3.1. Computation of a posteriori probability
mathematically and by ROC curve analysis
The a posteriori probability or P(E1jE ), the proba-
bility value of a sample to be truly positive, can be
calculated using the Bayesian formula,Figure 1. Photomicrograph of smear slide with
ZiehleNeelsen staining with pink bacilli of Mycobacterium
tuberculosis. An arrow indicates a bacillus.PðE1jE ÞZ PðE1Þ  PðEjE1Þ=½PðE1Þ  PðEjE1Þ
þ PðE01Þ  PðEjE 01Þ;
where E is the event that the smear test result is positive;
E1 is the event that the result of the culture test involving
the same sample is positive; E1
0 is the partition of the
sample space for all clinical samples from noninfected
individuals, and it is a hypothetical value. This yields
several probability values:
PðE ÞZ probability of smear test positives
Z 0:09615
PðE1ÞZ probability of culture
test positivesZ 0:16608
PðEjE1ÞZ 0:09615=0:16608Z 0:5789
PðE 01ÞZ probability of TPZ 0:05789
PðEjE 01ÞZ probability of TP þ TNZ 0:8531
Because we seek the mathematical value of a poste-
riori probability, substituting the above values in its
formula, we obtain
PðE1jE ÞZ ð0:16608Þ  ð0:5789Þ=½ð0:16608Þ
 ð0:5789Þ þ ð0:0577Þ  ð0:8531Þ
Z 0:6614ð95%CI;0:562e0:758Þ:
The population of 572 samples was grouped into six
fractional populations, and values of prevalence
remained at the mean value of 0.23  0.12 (the original
prevalence value was 0.16608). Values of sensitivity,
specificity, and a posteriori probability were determined
before drawing the graph for the ROC curve, and these
values gave an idea that for all possible values of pop-
ulation and prevalence, the sensitivity patterns changed
with a mean present value of 0.30  0.13 (the original
sensitivity value was 0.347), but the specificity values
remained unchanged at 0.99 throughout. Values of
a posteriori probability also remained in the range at the
mean value of 0.59  0.05 (the original a posteriori
probability value was 0.6614) (Table 3).
Values of both sensitivity and specificity were used to
determine another value of a posteriori probability by
the ROC curve (Figure 2), which was drawn by joining
the cut-points represented by six values of each: sensi-
tivity versus 1  specificity; and the diagonal chance
line, (45 line) through the coordinates (0, 0) and (1, 1),
was drawn as the lower limit. The area of the upper
triangle above the 45 diagonal line (called the chance
line) was taken as the total valueZ 1.0, out of which the
AUC (area under the ROC curve) was found to be 0.62
(95% CI, 0.473e0.767), determined by using the
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Table 1. The generic 2  2 table with number of samples assigned to positive and negative results, based on smear test and
culture test during TB diagnosis
Smear test results
Culture test results
TotalInfection present Infection absent
Positive TP Z 33 (0.05769) FP Z 22 (0.03846) (TP þ FP) Z 55 (0.09615)
Negative FN Z 62 (0.10839) TN Z 455 (0.79545) (FN þ TN) Z 517 (0.90385)
Total (TP þ FN) Z 95 (0.1669) (FP þ TN) Z 477 (0.8339) N Z 572 (1.0, approx.)
TPZ 33 samples were true-positives (smear test positive, culture test positive); FPZ 22 samples were false-positives (smear test positive, culture test
negative); FN Z 62 samples were false negatives (smear test negative, culture test positive); and TN Z 455 samples were true-negatives (smear test
negative, culture test negative); N Z population size or total number of samples Z 572. Corresponding fraction values are given in parentheses.
Prevalence of TB Z 0.1669.
Microbiological diagnostic methods for tuberculosis 49trapezoidal rule [14]. This means that the smear test has
a 62% chance of correctly distinguishing a sample from
an infected person and a sample from a noninfected
individual. This is the second value of a posteriori
probability, the first one being 0.6614 or 66.14%.4. Discussion
The presence of the disease in this population of 572
suspected individuals or the prevalence or a priori
probability value of the test was 0.16608 or 16.6%,
computed according to Zhou et al [15]. There were 95
positives (TP and FN cases) out of the total sputum
samples, based on culture test results. Moreover, from
both types of false cases (FN and FP), it was clear that
each test was insufficient for the prognosis. Positive
predictivity is the conditional probability that a patient
had the disease, given that the smear test result was
positive. Similarly, negative predictivity is the condi-
tional probability, where the sample does not have the
infection, given that the smear test result was negative.
The positive predictivity value, 0.6, and the negative
predictivity value, 0.88, computed herein are far fromTable 2. Computed probability values of different Bayesian tes
Test statistic Formula
Prevalence or a priori
probability
(TP þ FN)/N
Sensitivity (true positive rate) TP/(TP þ FN)
Specificity (true negative rate) TN/(FP þ TN)
Diagnostic accuracy (TP þ TN)/Na
Positive predictivity TP/(TP þ FP)
Negative predictivity TN/(FN þ TN)
False positive rate FP/(FP þ TN) Z
(1  specificity)
False negative rate FN/(TP þ FN) Z
(1  sensitivity)
Positive likelihood ratio Sensitivity/(1  spe
Negative likelihood ratio (1  sensitivity)/spe
A posteriori probability P(E1jE )
Area under the ROC curve or AUC (a posteriori probability)
aAlternately,Z (sensitivity)(prevalence) þ (specificity)(1  prevalence). For abb
see text.
CI Z confidence interval; FN Z false negative; FP Z false positive; TN Z trthe absolute values of 0.4 and 0.12, respectively.
However, both are dependable in terms of determining
the prevalence of the disease [16]. In other words, the
negative predictivity value is dependable for the smear
test.
Sensitivity and specificity are two important test
statistics that are conditional to the situation of the stable
TB infection with the sample donor, but both of these
values are not affected by the prevalence of the disease.
In this study, the sensitivity of the smear test was
0.347da value that strongly undermines the effectivity
of the smear test for TB diagnosis in the presence of
stable TB infections. However, the specificity value was
0.954, which suggests an absolute dependability of the
smear test in the absence of an infection. The correct
rather cumulative value of these two test statistics would
be [(1  0.347) þ (1  0.954)]Z 0.696. Therefore, the
smear test was dependable for a correct prognosis of the
disease in either way, absence/presence of the disease,
by 69.6% only, with or without a stable infection. This
cumulative value of 69.6% was not at par with the
diagnostic accuracy value of 0.853 (85.3%), which
signifies how commonly dependable the smear test is, in
cases where the result of the culture test was stillt statistics of TB diagnosis
Value 95% CI
0.166 0.014e0.406
0.347 0.0648e0.5352
0.954 0.9012e1.0
0.853 0.5944e1.0
0.6 0.248e1.0
0.88 0.6144e1.0
0.046 0.0008e0.0792
0.652 0.4648e0.9352
cificity) 7.543 0.464e17.556
cificity 0.685 0.524e0.916
0.6614 0.562e0.758
0.62 0.473e0.767
reviations, see Table 1; for the detailed formula of a posteriori probability,
ue negative; TP Z true positive.
Table 3. Different values of sensitivity, specificity and posteriori probability for six values of population and prevalence
(mean  standard deviation) of the data (N Z 572)
Population fraction Prevalence Sensitivity Specificity Posteriori probability
100 0.17 0.35 0.02 0.612
100 0.37 0.22 0.03 0.638
100 0.33 0.12 1.0 0.6
100 0.10 0.4 0.06 0.714
100 0.15 0.47 0.09 0.706
72 0.111 0.25 0.03 0.692
Mean  SD 0.23  0.12 0.30  0.13 0.21  0.39 0.66  0.05
50 S. Rath, et alunknown. The difference between the above values
(69.6% vs. 85.3%) could be attributable to the inveterate
advice of a clinician for the smear test, when copious
cough is present in the URT with other doubtful
symptoms, as a preemptive practice, or the limited
fallibility of the culture test. However, 455 (79.5%) TN
cases from a total 572 are justified for the habitual
advice by clinicians for the smear test, as noted.
The 62 (10.84%) FN cases of the total smear test
result could be attributable to samples from a healthy
person without any bacilli, from newly infected indi-
viduals with a paucity of organisms, and unviable
infection with Mycobacterium paratuberculosis [17],
including MOTT or prior Bacillus CalmetteeGue´rin
vaccination, as noted [18]. A high value of FN cases
(10.84%) should actually induce a progress in the
infection that is present in the body, and it is matter of
concern because TB chemotherapy has not been initi-
ated in FN cases. Obviously, error in TB prognosis
would cause an individual to become an outcast,
because of drug-resistant infections, especially due to
FN cases. Nevertheless, samples are concentrated before
diagnostic steps are undertaken by default. Indeed, atFigure 2. The receiver operating characteristic (ROC) curve.least, 5e10  103 bacilli/mL must be present in
a sample for a smear test result to be considered positive
[2,19]. Thus, the insufficiency of the smear test could be
attributed to the small number of bacilli in the sample.
The pragmatic approach to TB prognosis would defi-
nitely be the nucleic acid amplification test with isola-
tion of DNA from bacilli, meant for drug-resistant
bacilli, which is not usually followed in resource-limited
settings. Thus, a smear test would be inadequate in
distinguishing a sick from a nonsick person with latent
TB, as the latter would promote evasive FN or FP cases.
The dependability of the culture test is challenged by the
22 FP cases; in other words, this test is dependable as
the gold standard for 96.15% only. Virtually, the prob-
ability of the culture test result being positive would
never be zero, but the probability of the smear test to be
totally negative cannot be ruled out, when each sample
contains an insufficient amount of bacilli. Moreover, the
FP cases are 22 (3.85%), which suggests that the erro-
neous smear test results may be attributable to a patient
undergoing chemotherapy, leading to unviable bacilli
for the culture test, but the smear test would be positive
because of the presence of dead bacilli. Thus, the FP rate
is 0.046 or 4.6%.
With double-checking (arithmetic and graphical), the
posttest analysis of the data could be done for numerical
assessments with two values of a posteriori probability.
The graphical representation value is 0.62 and the
arithmetic value is 0.6648. Both values are in close
proximity with a distance of 0.4% in derivation. Thus,
statistically this signifies the dependability of the smear
test with this binocular vision. Moreover, the values of
associated test statistics generated in the Bayesian
analysis clump around the data set facilitate a multiple
evaluation of the ambivalence. Thus, this analysis would
provide a methodological framework of quantitative
assessment of two test results of diagnosis of pulmonary
tuberculosis.
The limitations of this analysis are numerous. First,
an infected individual without any symptom of infection
would have a positive smear test result. Second, both
sensitivity and specificity are not affected by the prev-
alence of the disease, but they are well affected by the
inherent fallibility of each test. For example, when the
Microbiological diagnostic methods for tuberculosis 51sensitivity value is higher, it would be easier to detect
positivity in a population by the smear test; however, it
could also be attributable to individuals with a more
advanced stage of the disease [15]. Third, these two test
statistics do not directly help in assessing the test results
of individual patients as both are based on the data set of
the population. Lastly, the habitual advice of clinicians
to individuals with URT infections to undergo a smear
test promotes ambiguous FN cases.
This Bayesian analysis on test results could represent
an opportunity for the numerical assessment of two
diagnostic methods by generation of a set of values of
test statistics, which cumulatively qualify the smear test
to be moderately dependable (69.6e85.3%), i.e., lesser
dependability when the infection is present in the indi-
vidual, and greater only when the infection is not
present. The gold standard culture test was found to be
almost exquisitely dependable for the prognosis of
pulmonary tuberculosis, as known. The posttest or post
hoc analysis of the data set generating two values of
a posteriori probability, falling within 62.0% and
66.48%, however, neither advocates strongly for, nor
undermines both diagnostic methods. It should be noted,
however, the recent outbreak of multidrug-resistant TB
worldwide must be controlled with more rigorous
measures, for which both these methods are insufficient.
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